Quercetin and related chromenone derivatives as monoamine oxidase inhibitors: Targeting neurological and mental disorders
MetadataShow full item record
Monoamine oxidase inhibitions are considered as important targets for the treatment of depression, anxiety, and neurodegenerative disorders, including Alzheimer’s and Parkinson’s diseases. This has encouraged many medicinal chemistry research groups for the development of most promising selective monoamine oxidase (MAO) inhibitors. A large number of plant isolates also reported for significant MAO inhibition potential in recent years. Differently substituted flavonoids have been prepared and investigated as MAO-A and MAO-B inhibitors. Flavonoid scaffold showed notable antidepressant and neuroprotective properties as revealed by various and established preclinical trials. The current review made an attempt to summarizing and critically evaluating the new findings on the quercetin and related flavonoid derivatives functions as potent MAO isoform inhibitors. © 2019 by the authors.
Showing items related by title, author, creator and subject.
Synthesis and structure-activity relationship study of novel 3-heteroarylcoumarins based on pyridazine scaffold as selective MAO-B inhibitors (2020) Costas-Lago M.C.; Besada P.; Rodríguez-Enríquez F.; Viña D.; Vilar S.; Uriarte E.; Borges F.; Terán C. (Elsevier Masson SAS, 2017)
Multi-target-directed ligands for Alzheimer's disease: Discovery of chromone-based monoamine oxidase/cholinesterase inhibitors (2020) Reis J.; Cagide F.; Valencia M.E.; Teixeira J.; Bagetta D.; Pérez C.; Uriarte E.; Oliveira P.J.; Ortuso F.; Alcaro S.; ... (Elsevier Masson SAS, 2018)
ReviewVilar S.; Sobarzo-Sánchez E.; Santana L.; Uriarte E. (Bentham Science Publishers B.V., 2018)